In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors

Despite vaccines are the main strategy to control the ongoing global COVID-19 pandemic, their effectiveness could not be enough for individuals with immunosuppression. In these cases, as well as in patients with moderate/severe COVID-19, passive immunization with anti-SARS-CoV-2 immunoglobulins coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas-Jiménez, Gabriel, Solano, Daniela, Segura, Álvaro, Sánchez, Andrés, Chaves-Araya, Stephanie, Herrera, María, Vargas, Mariángela, Cerdas, Maykel, Calvo, Gerardo, Alfaro, Jonathan, Molina, Sebastián, Bolaños, Kimberly, Moreira-Soto, Andrés, Villalta, Mauren, Sánchez, Adriana, Cordero, Daniel, Durán, Gina, Solano, Gabriela, Gómez, Aarón, Hernández, Andrés, Sánchez, Laura, Vargas, Marco, Drexler, Jean Felix, Alape-Girón, Alberto, Díaz, Cecilia, León, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medical Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757726/
https://www.ncbi.nlm.nih.gov/pubmed/35047966
http://dx.doi.org/10.3389/fmedt.2021.772275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757726/
https://www.ncbi.nlm.nih.gov/pubmed/35047966
http://dx.doi.org/10.3389/fmedt.2021.772275

Ejemplares similares